Boston Biolab Defeats Bids to Ban Deadliest Microbes

Global Security Newswire Staff
Add to Briefcase
Global Security Newswire Staff
May 15, 2014, 8:46 a.m.

Bo­ston Uni­versity over­came two bids to pre­vent a down­town site from study­ing some of the world’s dead­li­est bio­lo­gic­al agents, the Bo­ston Her­ald re­ports.

The Bo­ston City Coun­cil on Wed­nes­day voted down a pro­pos­al to pro­hib­it loc­a­tions in the city from car­ry­ing out “Biosafety Level 4” stud­ies, which can in­volve dis­eases for which there are no known cures. The meas­ure tar­geted the Na­tion­al Emer­ging In­fec­tious Dis­eases Labor­at­or­ies, a 6-year-old site where Bo­ston Uni­versity wants to con­duct such re­search.

The chief pro­ponent of the re­search ban de­scribed the coun­cil’s 8-5 de­cision as a let­down.

“Many oth­er sur­round­ing com­munit­ies have banned [Biosafety] Level 4 re­search to pro­tect their res­id­ents from a po­ten­tial risk,” said Coun­cilor Charles Yan­cey, who sub­mit­ted an or­din­ance to pro­hib­it the sens­it­ive sci­entif­ic ef­forts.

“I don’t be­lieve that the city of Bo­ston is pre­pared to deal with an emer­gency res­ult­ing from the re­lease of a patho­gen,” he said.

Mean­while, a uni­versity ad­min­is­trat­or praised the coun­cil’s de­cision.

“At the end of the day it was the safety meas­ures and the se­cur­ity of the build­ing that car­ried the vote,” Michelle Con­salvo, as­sist­ant vice pres­id­ent for gov­ern­ment and com­munity af­fairs, said in the school pub­lic­a­tion BU Today.

Also on Wed­nes­day, a state court re­jec­ted a loc­al chal­lenge to a Na­tion­al In­sti­tutes of Health find­ing that the labor­at­ory con­sti­tutes a re­l­at­ively in­sig­ni­fic­ant haz­ard to the sur­round­ing area.

“When as­sess­ing the risk … the re­port as­sumed that in each scen­ario, everything that could go wrong would go wrong,” Suf­folk County Su­per­i­or Court Judge Janet Sanders wrote in her rul­ing. “It then cal­cu­lated the risk that this could hap­pen us­ing a spe­cif­ic meth­od­o­logy.”

The labor­at­ory must still ob­tain au­thor­iz­a­tion from the Bo­ston Pub­lic Health Com­mis­sion to con­duct Biosafety Level 4 re­search.

What We're Following See More »
By a Big Margin, House Passes Defense Bill
57 minutes ago

The National Defense Authorization Act passed the House this morning by a 375-34 vote. The bill, which heads to the Senate next week for final consideration, would fund the military to the tune of $618.7 billion, "about $3.2 billion more than the president requested for fiscal 2017. ... The White House has issued a veto threat on both the House and Senate-passed versions of the bill, but has not yet said if it will sign the compromise bill released by the conference committee this week."

Michigan Attorney General Sues to End Recount
2 hours ago

Bill Schuette, Michigan's attorney general, has filed a lawsuit on behalf of the state to halt the recount of the state's voting results. The recount was elected by Green Party candidate Jill Stein. Schuette says the recount shouldn't occur because Stein cited no evidence of voter fraud or tabulation error.

Walden to Chair Energy and Commerce Committee
2 hours ago

"Republicans have elected Rep. Greg Walden (R-OR) the next chairman of the powerful House Energy and Commerce Committee. Walden defeated Reps. John Shimkus (R-IL) and Joe Barton (R-TX), the former committee chairman, in the race for the gavel" to succeed Michgan's Fred Upton.

Economy Added 178,000 Jobs in November
4 hours ago

The economy added 178,000 jobs in November, up from just 142,000 in October. Unemployment dropped to 4.6% from 4.9%, making it the lowest rate since before the Great Recession.

Senators Looking to Limit Deportations Under Trump
19 hours ago

"Democratic and Republican members of the Senate Judiciary Committee are working on legislation that would limit deportations" under President-elect Donald Trump. Leading the effort are Judiciary Committee members Dick Durbin (D-IL) and Lindsey Graham (R-SC). Sen. Jeff Flake (R-AZ) is also expected to sign on.


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.